Pay in 4 interest-free payments of $25.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
WO2017181117A1
non-imidazole histamine H3 receptor antagonist
51(11):669-75
and induces apoptosis at 10 μM
Ivabradine Hydrochloride b Mesylate WO2017181117A1Ivabradine is a novel medication used for the symptomatic management of stable angina pectoris. Ivabradine acts by reducing the heart rate via specific inhibition of the funny channel, a mechanism different from that of beta blockers and calcium channel blockers, two commonly prescribed antianginal drugs. Ivabradine is a cardiotonic agent. Ivabradine was approved in 2015. Ivabradine acts on the If (f is for "funny", so called because it had unusual
US$ 4000.00
US$ 4400.00
US$ 3250.00
US$ 2900.00
US$ 1250.00
US$ 2250.00
US$ 2900.00
US$ 3250.00
US$ 2900.00
US$ 28.00